Investor profile

Golden Seeds logo

Golden Seeds

Angel syndicate

USB2B SaaSAI/MLHealthtechConsumerEnterpriseBio/PharmaCybersecurity

See how your deck fits this investor's thesis, stage, and ticket size.

Analyse your fit

Investment thesis

Golden Seeds invests in early-stage, women-led U.S. companies with strong leadership, scalable models, and market potential. Typical rounds range from $250K–$2M, with valuations under $10M, across B2B & B2C technologies, health care, and consumer products or services. The firm's thesis rests on extensive research showing that gender-diverse teams produce better returns: companies in the top quartile for gender-diverse executive teams are 39% more likely to have above-average profitability (McKinsey, 2023), and women-founded companies generate 78 cents of revenue per dollar of funding versus 31 cents for male-founded companies. Founded in 2004 by a group of Wall Street women, Golden Seeds has grown into one of the largest angel networks in the U.S., with 9 chapters, 1,150+ investors, and over $200 million deployed into 275+ companies that have gone on to raise $2.5B+ in follow-on capital. The organization combines direct angel investing with member-managed venture funds (Golden Seeds Venture Fund and Golden Seeds Fund 2), investor education through the Knowledge Institute, and active post-investment support including board participation and introductions.

Notable quotes

Fifteen years ago, when I first attended an Angel Capital Association meeting, 10% of attendees were women. Now it's 35% to 40%.

Jo Ann Corkran · Forbes, 'Golden Seeds At 20: Empowering Women, Transforming Angel Investing' · 2024-09-11

Women are getting levels of education, experience, and skills to be [angel investors and founders]. We are thrilled about that.

Loretta McCarthy · Forbes, 'Golden Seeds At 20: Empowering Women, Transforming Angel Investing' · 2024-09-11

Angel investing is a team sport. Being part of a network of investors allows you to tap into the diversity and breadth of expertise within the group, which we feel substantially elevates the quality of due diligence.

Loretta McCarthy · Davis Wright Tremaine Q&A, 'Golden Seeds 20 Years Later' · 2024-11-14

Team

Jo Ann Corkran

Co-CEO and Managing Partner

B2B SaaSAI/MLEnterprise

Loretta McCarthy

Co-CEO and Managing Partner

HealthtechConsumerB2B SaaS

Matias Healy

Senior Analyst

Alison Hart

Director of Finance

Alana Lyons

Manager of Entrepreneur Relations

Kevin Silver

Investment Operations Specialist

Recent investments

CompanyRoundSizeDate
EliseAISeed
Alcatraz AISeries A
Work Truck SolutionsSeed2014-01-01
Concerto BiosciencesSeries A$23m
Materna MedicalSeries A$22m
BrandwatchSeed
PolyGone SystemsSeed$5m2026-02-19
NullspaceSeed$4m2025-08-19
Avisi TechnologiesSeries A$11m2026-02-26
OsteoboostSeries A$8m2026-04-15

Frequent co-investors

Fit check

Is Golden Seeds a match for your startup?

Upload your deck and get an instant AI-powered fit analysis — see exactly how your startup aligns with this investor's thesis, stage focus, and ticket size.

Analyse your fit